Article
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
Journal of hepatology - 1 Sept 2012
Stättermayer Albert Friedrich, Rutter Karoline, Beinhardt Sandra, Scherzer Thomas-Matthias, Stadlmayr Andreas, Hofer Harald, Wrba Fritz, Steindl-Munda Petra, Krebs Michael, Datz Christian, Trauner Michael, Ferenci Peter
Abstract excerpt
BACKGROUND & AIMS: Insulin resistance, fibrosis and steatosis are established predictors of response to peg-interferon/ribavirin therapy in chronic hepatitis C (CHC). Several host genetic polymorphisms (IL28B, PNPLA3) modify treatment-outcome, the degree of steatosis or fibrosis. The aim of our study was to evaluate the role of these polymorphisms on insulin resistance (IR) in treatment-naïve patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
